195 related articles for article (PubMed ID: 21451396)
1. Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients.
Lim MY; Pruthi RK
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):402-6. PubMed ID: 21451396
[TBL] [Abstract][Full Text] [Related]
2. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
Sharathkumar AA; Soucie JM; Trawinski B; Greist A; Shapiro AD
Haemophilia; 2011 Jul; 17(4):597-604. PubMed ID: 21323799
[TBL] [Abstract][Full Text] [Related]
4. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15).
Mehta S; Wells S; Riddell T; Kerr A; Pylypchuk R; Marshall R; Ameratunga S; Chan WC; Thornley S; Crengle S; Harrison J; Drury P; Elley CR; Bell F; Jackson R
J Prim Health Care; 2011 Jun; 3(2):93-101. PubMed ID: 21625656
[TBL] [Abstract][Full Text] [Related]
5. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
7. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
[TBL] [Abstract][Full Text] [Related]
8. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
10. Lone mothers are at higher risk for cardiovascular disease compared with partnered mothers. Data from the National Health and Nutrition Examination Survey III (NHANES III).
Young LE; Cunningham SL; Buist DS
Health Care Women Int; 2005 Aug; 26(7):604-21. PubMed ID: 16126603
[TBL] [Abstract][Full Text] [Related]
11. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
12. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
Castelino RL; Chen TF; Guddattu V; Bajorek BV
Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
[TBL] [Abstract][Full Text] [Related]
13. Long-term stroke prognosis in relation to medical prevention and lifestyle factors. A prospective population-based study.
Li C; Engstrom G; Janzon L; Hedblad B
Cerebrovasc Dis; 2008; 25(6):526-32. PubMed ID: 18480605
[TBL] [Abstract][Full Text] [Related]
14. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
[TBL] [Abstract][Full Text] [Related]
16. HIV infection, aging and cardiovascular disease: epidemiology and prevention.
Petoumenos K; Worm SW
Sex Health; 2011 Dec; 8(4):465-73. PubMed ID: 22127031
[TBL] [Abstract][Full Text] [Related]
17. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice.
Eaton CB; McQuade W; Glupczynski D
Fam Med; 1994 Oct; 26(9):587-92. PubMed ID: 7843510
[TBL] [Abstract][Full Text] [Related]
18. The impact of prevention on reducing the burden of cardiovascular disease.
Kahn R; Robertson RM; Smith R; Eddy D
Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
[TBL] [Abstract][Full Text] [Related]
19. [Chilean results of the international registry of risk factors and treatment of unstable angina and non ST elevation myocardial infarction: ACCORD (ACute CORonary syndrome Descriptive study)].
Stockins B; Albornoz F; Martínez D; Campos P; Gajardo J; Lamich R; Manríquez L; Pérez V; Rojo P; Sepúlveda P; Pumarino MG; Corbalán R
Rev Med Chil; 2011 Jan; 139(1):19-26. PubMed ID: 21526313
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
